Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
33 |
Employees |
- |
Revenues (TTM) (Millions $) |
11 |
Net Income (TTM) (Millions $) |
-27 |
Cash Flow (TTM) (Millions $) |
-29 |
Capital Exp. (TTM) (Millions $) |
0 |
Logicbio Therapeutics Inc
LogicBio Therapeutics Inc. is a gene editing and gene delivery company that focuses on developing innovative genetic medicines for patients with severe genetic disorders. The company utilizes its proprietary GeneRide platform, which enables site-specific integration of therapeutic genes into the patient's genome, to address the underlying genetic causes of diseases. LogicBio's goal is to provide long-lasting and potentially curative treatments for patients by correcting genetic mutations. The company is based in Lexington, Massachusetts, and collaborates with academic institutions, pharmaceutical companies, and foundations to advance its research and development efforts.
Company Address: 65 Hayden Avenue Lexington 2421 MA
Company Phone Number: 245-0399 Stock Exchange / Ticker: NASDAQ LOGC
|